Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Equity (2022 - 2025)

Historic Return on Equity for HeartSciences (HSCS) over the last 4 years, with Q4 2025 value amounting to 2.48%.

  • HeartSciences' Return on Equity fell 9200.0% to 2.48% in Q4 2025 from the same period last year, while for Oct 2025 it was 2.48%, marking a year-over-year decrease of 9200.0%. This contributed to the annual value of 2.35% for FY2025, which is 5900.0% down from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Return on Equity is 2.48%, which was down 9200.0% from 5.27% recorded in Q3 2025.
  • HeartSciences' 5-year Return on Equity high stood at 464.71% for Q2 2023, and its period low was 16.44% during Q1 2023.
  • In the last 4 years, HeartSciences' Return on Equity had a median value of 1.69% in 2024 and averaged 33.7%.
  • In the last 5 years, HeartSciences' Return on Equity soared by 387900bps in 2023 and then tumbled by -4655500bps in 2024.
  • Over the past 4 years, HeartSciences' Return on Equity (Quarter) stood at 3.35% in 2022, then surged by 267bps to 5.61% in 2023, then tumbled by -128bps to 1.56% in 2024, then tumbled by -59bps to 2.48% in 2025.
  • Its Return on Equity stands at 2.48% for Q4 2025, versus 5.27% for Q3 2025 and 8.89% for Q2 2025.